Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Core Laboratories Inc. /DE/ Director's Dealing 2023

Jul 7, 2023

32685_dirs_2023-07-07_cd89086a-7f01-46d6-adb3-8b11d96a7600.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Core Laboratories Inc. /DE/ (CLB)
CIK: 0001958086
Period of Report: 2023-06-28

Reporting Person: ANASTASIO CURT (Director)

Holdings (Non-Derivative)

Security Shares Ownership
Common Shares 0 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Restricted Shares $0.00 Common Shares (6419) Direct

Footnotes

F1: The Restricted Shares were granted to Mr. Anastasio upon his election to the Board of Directors of Core Laboratories Inc., as part of the annual grant given to all non-executive directors on April 1, 2023, and will vest, without performance criteria, on April 1, 2024, at the end of a one-year vesting period from the date of the original non-executive directors' grant, subject to the terms of issuance.